BI-847325, a novel ATP-competitive MEK/Aurora kinase inhibitor

Min.Order / FOB Price:Get Latest Price

5 Gram	Negotiable

5 Gram

Negotiable

Min.Order :5 Gram
Purity: 98%min
Payment Terms : T/T,Other

Keywords

BI-847325 1207293-36-4 (Z)-3-(3-(((4-((dimethylamino)methyl)phenyl)amino)(phenyl)methylene)-2-oxoindolin-6-yl)-N-ethylpropiolamide

Quick Details

Appearance:White solid
Application:BI-847325 induced a decrease in the expression of MEK and Mcl-1.
PackAge:Refer to customer's request
ProductionCapacity:100|Gram|Month
Storage:In dry and cool place with sealed container
Transportation:DHL or Fedex or others

Superiority:

Shanghai Caerulum Pharma Discovery was established in 2012 as an integrated CRO (Contract Research Organization), providing professional chemical services. As a customer-oriented company, Caerulum Pharma Discovery has distinguished itself from others in providing worldwide customers with cost-effective and efficient services and transparent communications to expedite the drug discovery and development. Caerulum Pharma Discovery has over 1300 square meters of laboratory space, equipped with over 30 fume hoods and multiple reactors (from 20 liters to 100 liters) in 4 standard laboratories and 4 pilot laboratories. Caerulum Pharma Discovery has built its capabilities in the production of APIs，intermediates and novel synthetic building blocks. APIs and intermediates projects have reached diabetes, cancer, cardiovascular and other therapeutic areas. Caerulum Pharma Discovery itemizes cost analysis for the customers to understand the scope of the projects. Conference calls and email will be preceded to update the progress of ongoing projects, with the weekly report including detailed information of each step of every batch. Caerulum Pharma Discovery strictly honors the confidentiality to protect any intellectual property of its customers. In the meantime, Caerulum Pharma Discovery will always stick to the principle of no infringement of the patents. Caerulum Pharma Discovery, YOUR reliable and efficient source of chemical services!

Details:

An Aurora kinase inhibitor

High quality, and low single impurity

HNMR, HPLC available

ROS, MOA, COA and MSDS will come along with consignment

Custom synthesis is acceptable

View All

Visit Store

BI-847325, a novel ...

BI-847325, a novel ATP-competitive MEK/Aurora kinase inhibitor

Keywords

Quick Details

Superiority:

Details:

You Might Also Like

(2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylicacid

6-(2,6-dichloro-3,5-dimethoxyphenyl)-N-(2-methyl-6-nitrophenyl)quinazolin-2-amine

1H-Azepine-1-carboxylic acid, 3-[7-chloro-2-[[(2-methyl-4-pyridinyl)carbonyl]amino]-1H-benzimidazol-1-yl]hexahydro-, 1,1-dimethylethyl ester, (3R)-

YS121

tert-butyl (3s,4s)-3-amino-4-hydroxypiperidine-1-carboxylate

tert-butyl (3R,4S)-3-amino-4-hydroxypiperidine-1-carboxylate

Related Searches

OK Cancel

BI-847325, a novel ...

BI-847325, a novel ATP-competitive MEK/Aurora kinase inhibitor

Keywords

Quick Details

Superiority:

Details:

You Might Also Like

(2S,4R)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)-4-hydroxypyrrolidine-2-carboxylicacid

6-(2,6-dichloro-3,5-dimethoxyphenyl)-N-(2-methyl-6-nitrophenyl)quinazolin-2-amine

1H-Azepine-1-carboxylic acid, 3-[7-chloro-2-[[(2-methyl-4-pyridinyl)carbonyl]amino]-1H-benzimidazol-1-yl]hexahydro-, 1,1-dimethylethyl ester, (3R)-

YS121

tert-butyl (3s,4s)-3-amino-4-hydroxypiperidine-1-carboxylate

tert-butyl (3R,4S)-3-amino-4-hydroxypiperidine-1-carboxylate

Related Searches

OKCancel

OK Cancel